Assessment of Functional Vision Score and Vision-Specific Quality of Life in Individuals With Retinitis Pigmentosa by Seo, Je Hyun et al.
164
접수번호: 2008-097 Korean Journal of Ophthalmology 2009;23:164-168
ISSN : 1011-8942 
DOI : 10.3341/kjo.2009.23.3.164
Assessment of Functional Vision Score and Vision-Specific 
Quality of Life in Individuals With Retinitis Pigmentosa
Je Hyun Seo, MD, Hyeong Gon Yu, MD, Byung Joo Lee, MD
Department of Ophthalmology, College of Medicine, and Medical Research Center, Seoul National University, Seoul, Korea
Purpose: To determine the relationship between the American Medical Association’s (AMA) functional vision score 
(FVS) and vision-specific quality of life in retinitis pigmentosa (RP) patients using the National Eye Institute’s Visual 
Functioning Questionnaire (NEI-VFQ 25). 
Methods: One hundred eight patients with RP participated in the study. We measured best-corrected visual acuity, 
conducted Goldmann perimetry, and collected the self-reported NEI-VFQ 25. The FVS was calculated using the 
functional field score (FFS) and the functional acuity score (FAS). The correlations of the VFQ composite scores 
to the FVS, FFS, and FAS were determined using correlation and regression analyses. 
Results: FVS was highly correlated to the BCVA (r=0.69, p<0.001), the FFS (r=0.86, p<0.001) and the FAS (r= 
0.73, p<0.001). Significant correlations of the VFQ composite score to the BCVA (r=0.60, p<0.001), FFS (r=0.44, 
p<0.001), FAS (r=0.60, p<0.001), FVS (r=0.58, p<0.001) were also found. However, the correlation strengths of 
BCVA, FVS, FAS, and FFS to NEI-FVQ were not different. 
Conclusions: In RP patients, the vision-specific quality of life was correlated with the AMA guidelines’ FVS, FFS, 
and FAS. Their correlation degrees to NEI-FVQ were not different. This result suggests that vision-specific quality 
of life can be explained by both visual acuity and visual field in RP patients.
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Retinitis pigmentosa (RP), which leads to retinal degenera-
tion, is characterized by nyctalopia, intraretinal bony specule 
pigmentation, vessel attenuation, rod-cone dysfunction as de-
termined by electroretinogram and progressive visual field loss 
leading to blindness.
1 Impaired vision can be evaluated by mea-
suring visual acuity (VA) or by visual field test.
2 However, these 
measurements alone are of limited value in evaluating vision- 
specific quality of life; hence, several studies
3-6 have been con-
ducted to document visual function and measure performance 
in RP patients. Recently, the National Eye Institute’s Visual 
Functioning Questionnaire (NEI-VFQ 25) composite scores 
were suggested for evaluating vision-specific quality of life, 
and the reliability of this method was proved in several studies 
for chronic diseases (glaucoma, ARMD).
7,8 The previous stu-
dies, however, did not evaluate the relationship between vision- 
specific quality of life and the American Medical Association 
(AMA) guidelines’ functional vision score (FVS) in RP patients. 
The AMA guidelines’ FVS was reported to be a better predictor 
of vision-targeted quality of life than traditional measurements 
of visual acuity or visual field extentin disease.
9 However, it 
still remains unclear whether the vision-specific quality of life 
correlates with objective visual measurements in retinal diseases 
such as RP. 
In this study, we measured the best-corrected visual acuity 
(BCVA) and visual field extent while collecting data from the 
self-reported NEI-VFQ 25 from RP patients to determine the 
relationship of the FVS and vision-specific quality of life. We 
also analyzed the effect of each visual measurement to the 
quality of life in order to evaluate the importance of each vi-
sual scale in RP patients at different clinical stages. To our 
knowledge, our study offers the first report of the correlation 
of FVS to vision-specific quality of life in RP patients using 
the NEI-VFQ 25. 
Materials and Methods
We enrolled 108 volunteers (65 males, 43 females) with RP, 
ranging in age from 16 to 85 years, who were members of the 
Korean Retintis Pigmentosa Society. A Korean national RP 
survey was conducted at Seoul National University Hospital’s 
retinal clinic from July to December 2006. RP was diagnosed 
in the recruited patients on the basis of a fundus examination, 
Goldmann perimetry, and a complete electroretinographic JH Seo, et al. ASSESSMENT OF FUNCTIONAL VISION SCORE IN RP 
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Table 1. Classification of functional vision score
11
Class Description Estimated ability to perform activities of daily living FVS (points)
1 Range of normal vision Retained reserve capacity >90
2 Near-normal vision Lost reserve capacity 71-90
3 Moderately low vision Need for visual enhancement of aids 51-70
4 Severely low vision Slower than normal, even with enhancement aids 31-50
5 Profoundly low vision Marginal visual performance, even with aids 11-30
6 Total blindness Cannot perform, needs substitution aids <10
FVS=functional vision score according to AMA guides. 
Source: Guides to the evaluation of permanent impairment, fifth edition, copyright 2001, American Medical Association.
Table 2. Demographic and clinical characteristics of enrolled patients (n=108)
Variables Mean±SD (Range) Variable n, (percent)
Age (years) 37.6±13.0 (13.0-85.0) Gender (male %) 65, (60.1 %)
Disease duration (years) 19.1±12.9 (1-58 ) FVS Class distribution 4.9±0.8  (1-6)
Onset age (years) 19.0±14.9 (1-80 ) 1 0, (0 %)
BCVA OD 0.81±0.68 (0.0-2.3) 2  0, (0 %)
      OS  0.78±0.68 (0.0-2.3) 3 5, (4.6 %)
BCVA better eye 0.63±0.58 (0.0-2.3) 4 23, (21.3 %)
FVS 21.3±16.1 (0.0-68.5) 5 50, (46.3 %)
FFS 29.7±17.1 (0.8-69.2 ) 6 30, (18.5 %)
FAS 65.3±27.9 (0.0-100.0 )
NEI-VFQ 
 General vision 37.2±17.6 (0.0-80)
 Ocular pain 71.3±24.9 (0.0-100)
 Near vision 55.6±29.3 (8.3-100)
 Distant vision 49.2±22.7 (0.0-91.7)
  Vision-specific social function 61.9±26.3 (12.5-100)
  Vision-specific mental health 42.3±26.2 (0.0-100)
  Vision-specific role difficulty 39.7±30.5 (0.0-100)
  Vision-specific dependency 58.6±27.0 (0.0-100)
  Driving 57.5±28.9 (0.0-100) 
  Color vision 72.5±30.7 (0.0-100)
  Peripheral vision 46.3±25.8 (0.0-100)
  Composite score 50.8±19.8 (14.6-95.9)
FVS=functional vision score; FFS=functional field score; FAS=functional acuity score; NEI-FVQ=National Eye Institute’s Visual Functioning 
Questionnaire.
evaluation according to the parameters of the International 
Society for Clinical Electrophysiology of Vision (ISCEV). 
Patients with hearing impairment (Usher syndrome) or other 
systemic diseases were excluded. However, patients with rea-
ding difficulties due to low vision were not excluded. The re-
searchers assisted these patients in completing the question-
naires. Patients were given the option of dropping out of the 
study. Our Institutional Review Board (IRB) approved the study 
protocol, informed consent was obtained from all of the sub-
jects, and all procedures used were consistent with the tenets 
of the Helsinki Declaration. All of the patients underwent a 
thorough ophthalmic examination including best-corrected vi-
sual acuity (BCVA), binocular indirect ophthalmoscopy, fundus 
examination, and Goldmann perimetry. If a definite diagnosis 
of RP could not be made, a standard electroretinogram was 
performed for confirmation.
Visual acuity measurement and visual field examination
The BCVA was measured using Snellen Visual Acuity Charts 
and was converted into a logarithm of the minimum angle of 
resolution (log MAR) VA scale. Monocular visual fields were 
measured by Goldmann perimetry using the Ⅲ-4-e target at a 
standard luminance. Along each meridian, the target was pre-
sented from a position of non-seeing to seeing, moving clock-
wise. All of the BCVA and perimetry measurements were per-
formed by skilled technicians.
Functional assessment according to the guidelines
The AMA has published guidelines
10,11 for the evaluation 
of permanent impairment. The FVS was calculated from the 
functional acuity score (FAS) and the functional field score Korean J Ophthalmol Vol.23, No.3, 2009
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Table 3. Correlation of the American Medical Association functional vision scores to retinitis pigmentosa patients
FVS BCVA FAS FFS
BCVA r=0.69, p<0.001
FAS r=0.73, p<0.001 r=0.94, p<0.001
FFS r=0.86, p<0.001 r=0.38, p<0.001 r=0.39, p<0.001
NEI-VFQ r=0.58, p<0.001 r=0.60, p<0.001 r=0.60, p<0.001 r=0.44, p<0.001
BCVA=best-corrected visual acuity; FVS=functional vision score; FFS=functional field score; FAS=functional acuity score; NEI-VFQ 
=composite score.
Spearman correlation analysis, two-sided p-values of <0.05 were considered statistically significant.
Table 4. Comparison of functional acuity score and functional field score between the better visual acuity group and
worse visual acuity group 
Variables Better VA group (n=46) Worse VA group (n=62) p-value
*
Age (years) 34.7±9.7 39.8±14.7 0.03
Gender (male %) 35, 76 % 30, 48.2% 0.84
Disease duration (years) 16.6±12.5 20.8±13.0 0.13
Age of onset (years) 17.8±10.2 19.8±17.4 0.49
BCVA OD 0.41±0.56 1.09±0.60 <0.001
           OS 0.31±0.37 1.13±0.64 <0.001
BCVA, better eye 0.18±0.13 0.97±0.55 <0.001
FVS=functional vision score; FFS=functional field score; FAS=functional acuity score; VA=visual acuity.
* Independent t-test, two-sided p-values of <0.05 were considered statistically significant.
(FFS), as defined in the aforementioned guidelines.
10,11 VA 
measurements were converted to a visual acuity score (VAS). 
The weighted average of three VASs for each field was used 
to calculate the FAS according to: FAS=(VASOD+VASOS+3× 
VASOU)/5. 
To evaluate the FFS, the visual field score (VFS) for the right 
monocularfield (VFSOD), the left monocular field (VFSOS), 
and the binocular field (VFSOU) were first scored separately:
FFS=(VFSOD+VFSOS+3×VFSOU)/5.
The FAS and FFS were then multiplied to yield the FVS:
FVS=FAS×FFS/100. 
The AMA FVS classification (Table 1) was used to classify 
patients.
11
Self-Reported Questionnaire (NEI-VFQ 25)
The NEI-VFQ 25-item version with appendix
7,8 (a total of 
39 items) was administered by skilled interviewers and scored 
in the standard manner. There were twelve sub-scale scores 
and one composite score. The NEI-VFQ 25 composite score was 
the average of all available sub-scales, except general health, 
and was suggested as the vision-related quality of life indicator 
by the NEI.
Statistical analysis
The correlations of the NEI-VFQ 25 composite score to the 
FVS, FFS, and FAS were analyzed by the Spearman correla-
tion test. If the correlations were significant, Fisher’s Z-trans-
formation analysis was used to determine the better predictor 
of vision-specific quality of life among the FVS, FFS, and FAS. 
A regression analysis was performed to determine regression 
equations. As the median log MAR was 0.6, we divided the 
patients into two groups according to that value: the better VA 
group (logMAR<0.6), and the worse VA group (logMAR≥0.6). 
In each group, the relationship of theVFQ composite score to 
the FVS, FFS, and FAS was evaluated and regression analysis 
was performed. Statistical analyses were performed using SPSS 
v.12.0 software (SPSS Inc., Chicago, IL), and two-sided p- 
values of <0.05 were considered statistically significant.
Results
As stated above, there were 108 RP patients enrolled (65 
males, 43 females) ranging in age from 16 to 85 years. The mean 
age of the subjects was 37.6±13.0 years. Their VA ranged from 
0.0 to 2.3 log MAR. The demographics and descriptive stati-
stics for the clinical measures of visionare listed in Table 2. Most 
participants were classified into more advanced categories 
(FVS 4, 5, 6).
FVS was highly correlated to the BCVA (r=0.69, p<0.001), 
FFS (r=0.86, p<0.001) and the FAS (r=0.73, p<0.001) (Table 
3). Significant correlations of the VFQ composite score to 
BCVA (r=0.60, p<0.001), FFS (r=0.44, p<0.001), FAS (r=0.60, 
p<0.001), FVS (r=0.58, p<0.001) were also found. However, 
we could not find any differences among the correlations of 
BCVA, FVS, FFS, and FAS to the VFQ composite score. 
Study patients were older in the poor VA group than in the 
better VA group (34.7±9.7 vs. 39.8±14.7, p=0.03, Table 4). 
Multiple regression analysis was performed as follows with 
the interactive forms of FFS and FAS.
(All patients, n=112), NEI-FVQ composite=0.30×FAS+ JH Seo, et al. ASSESSMENT OF FUNCTIONAL VISION SCORE IN RP 
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0.31×FFS+21.72, (r
2=0.40).
(Better VA group, n=50), NEI-FVQ composite=1.50×FAS 
+2.91×FFS-2.78×FVS-86.11 (r
2=0.37).
(Worse VA group, n=62), NEI-FVQ composite=0.24×FAS 
+0.23×FFS-2.78+25.8 (r
2=0.22).
 
Discussion
Our results indicate that in RP patients, BCVA and the AMA 
guidelines’ FVS, FFS, and FAS are equally correlated to those 
of the self-reported VFQ. Several other studies
6,12 evaluating 
the performance of RP patients demonstrated that reading per-
formance correlates with contrast sensitivity, VA, and visual 
field, while driving performance is the primary correlate of 
visual field loss. In fact, one of the conclusions of the work is 
that FVS is no better than BCVA (correlation: 0.60) for cate-
gorizing RP patients in terms of self-perceived QOL. This can 
be expected since the visual functioning of RP patients can be 
estimated from BCVA on average, although contrast sensitivity 
may add information.
To assess performance function, several studies
7-9 utilized 
questionnaires or AMA guidelines for FVS. According to the 
results, the VFQ is a reliable, valid method that should be use-
ful for group-level comparisons of vision-specific quality of 
life in clinical research. The FVS has also been found to be a 
potent predictor of self-reported vision-specific quality of life. 
However, these studies
9,13,14 did not focus on RP patients. Our 
study confirmed that the BCVA, FVS, FAS and FFS are highly 
correlated to the VFQ in RP patients. In accordance with our 
results, Szlyk et al. found that self-reporting is strongly correlated 
with actual task performancein RP patients.
5 The group evaluated 
the correlation of reading composite scores with contrast sen-
sitivity, whereas, in our study, we used the AMA’s FVS and 
VFQ composite score. However, compared with BCVA and 
FVS, it suggests that the FVS may not add much to the value 
of basic measures of visual function in some diseases. We could 
comment on previous research on the FVS in other diseases 
or in the general population, such as the study by Rubin et 
al.
15 who stated that monocular acuity and binocular acuity 
are significantly better predictors of reading speed than the 
AMA weighted score or a recently proposed Functional Vision 
Score (FVS).
In this study, the VFQ was affected by both the FFS and the 
FAS, although the regression equation had an interactive form 
(FVS). We speculate that these findings might reflect the fact 
that RP is a disease manifesting with progressive visual field 
loss. A hallmark feature of RP is an insidious, progressive loss 
of peripheral visual field. The peripheral island of visual field 
is lost before the central visual field contracts. Therefore, the 
remaining, functional field is important in advanced RP patients, 
as FFS represents visual field in the worse VA group. However, 
we cannot estimate the rate of visual field progression from 
our results, though Berson et al. suggested that the visual 
field is lost at a rate of about 4.6% per year.
16 Massof et al. 
proposed that the visual field diminishes approximately 50% 
over 4.5 years.
17 In any case, the rate of progression of visual 
field loss is usually slow and relentless in RP patients. 
The limitations of this study include its cross-sectional de-
sign, which does not allow for the assessment of the RP course. 
Because the enrolled patients presented with various stages of 
RP, selection bias could be an issue. Despite these limitations, 
our study is the first to determine the correlation of FVS to 
vision-specific quality of life in a relatively large group of RP 
patients. 
In conclusion, the vision-specific quality of life correlated 
with the AMA’s guidelines with FVS, FFS and FAS in RP 
patients. The correlations to the NEI-FVQ were not different. 
These results suggest that visual quality cannot be explained 
only by visual acuity or visual field in RP patients.
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